Ligand id: 7333

Name: metreleptin

No information available.
Summary of Clinical Use
First approved by the US FDA in Feb 2014, to treat leptin deficiency and its associated symptoms in patients with congenital or acquired generalized lipodystrophy.
Mechanism Of Action and Pharmacodynamic Effects
Acts to regulate adipose-tissue mass via the leptin receptor (LEPR).